Multiple Sclerosis research in Alberta will be receiving more funding from the provincial government.
The new Alberta Multiple Sclerosis Collaboration will combine the efforts of the government, Campus Alberta Neuroscience, and Sanofi Genzyme Canada to advance research and development in the field.
Alberta Economic Development and Trade is donation $500,000 to the initiative, an amount that will be matched by Sanofi Genzyme.
“The collaboration is intended to help attract other multinational industry enterprises to partner with Alberta’s innovation system,” the government said in a statement. “[The program will] accelerate health innovations, and provide economic and social benefits to Alberta.”
About 340 in every 100,000 Albertans are diagnosed with MS annually, one of the highest rates in the world.